Liang Cui-Li, Liu Li, Sheng Hui-Ying, Jiang Min-Yan, Yin Xi, Mei Hui-Fen, Cheng Jing, Zhang Wen, Fan Li-Ping
Department of Endocrinology and Metabolism, Guangzhou Women and Children's Medical Center, Guangzhou Medical College, Guangzhou 510623, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2013 Aug;15(8):661-5.
Glycogen storage disease type Ib (GSDIb) is caused by a deficiency of glucose-6-phosphate translocase (G6PT) activity due to SLC37A4 gene mutations. Most GSDIb patients have recurrent infections and inflammatory bowel disease, with poor prognosis. Detection of SLC37A4 gene mutations is of great significance for the diagnosis, subtyping and outcome prediction of GSD patients. This study aims to analyze SLC37A4 gene mutations in Chinese GSDIb patients and to investigate the relationship between its genotypes and clinical manifestations.
All exons and their flanking introns of SLC37A4 gene in 28 Chinese children with a primary diagnosis of GSDIb were screened by PCR combined with direct DNA sequencing to detect SLC37A4 gene mutations.
Five SLC37A4 gene mutations were detected in 7 (25%) of the 28 children, i.e., p.Gly149Glu (9/13, 69%), p.Gly115Arg (1/13, 8%), p.Pro191Leu (1/13, 8%), c.959-960 insT (1/13, 8%) and c.870+5G>A (1/13, 8%).
In this study, c.959-960 insT is a novel mutation and p.Gly149Glu is the most common mutation. p.Gly149Glu may be associated with severe infections in children with GSDIb.
糖原贮积病Ib型(GSDIb)是由SLC37A4基因突变导致葡萄糖-6-磷酸转运体(G6PT)活性缺乏引起的。大多数GSDIb患者有反复感染和炎症性肠病,预后较差。检测SLC37A4基因突变对GSD患者的诊断、分型及预后预测具有重要意义。本研究旨在分析中国GSDIb患者的SLC37A4基因突变情况,并探讨其基因型与临床表现之间的关系。
采用聚合酶链反应(PCR)结合直接DNA测序技术,对28例初诊为GSDIb的中国儿童的SLC37A4基因所有外显子及其侧翼内含子进行筛查,以检测SLC37A4基因突变。
28例儿童中有7例(25%)检测到5种SLC37A4基因突变,即p.Gly149Glu(9/13,69%)、p.Gly115Arg(1/13,8%)、p.Pro191Leu(1/13,8%)、c.959 - 960 insT(1/13,8%)和c.870+5G>A(1/13,8%)。
本研究中,c.959 - 960 insT是一种新的突变,p.Gly149Glu是最常见的突变。p.Gly149Glu可能与GSDIb患儿的严重感染有关。